Semaphorin 6C Antibody [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # AF2219Y
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Semaphorin 6C
Ala25-Val601
Accession # Q9H3T2
Ala25-Val601
Accession # Q9H3T2
Specificity
Detects human Semaphorin 6C in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human (rh) Sema 3A, rhSema 3B, rhSema 6A, rhSema 6B, rhSema 7A, recombinant mouse (rm) Sema 3C, rmSema 3E, and rmSema 3F is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Semaphorin 6C Antibody [DyLight 680]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Semaphorin 6C
Alternate Names
Sema6C, Semaphorin Y
Gene Symbol
SEMA6C
Additional Semaphorin 6C Products
Product Documents for Semaphorin 6C Antibody [DyLight 680]
Product Specific Notices for Semaphorin 6C Antibody [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...